These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19235530)

  • 1. Effects of a selective cyclooxygenase-1 inhibitor in SKOV-3 ovarian carcinoma xenograft-bearing mice.
    Li W; Ji ZL; Zhuo GC; Xu RJ; Wang J; Jiang HR
    Med Oncol; 2010 Mar; 27(1):98-104. PubMed ID: 19235530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a cyclooxygenase-1-selective inhibitor in a mouse model of ovarian cancer, administered alone or in combination with ibuprofen, a nonselective cyclooxygenase inhibitor.
    Li W; Xu RJ; Lin ZY; Zhuo GC; Zhang HH
    Med Oncol; 2009; 26(2):170-7. PubMed ID: 18988002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of ovarian carcinoma in vivo.
    Li W; Zhang HH; Xu RJ; Zhuo GC; Hu YQ; Li J
    Med Oncol; 2008; 25(2):172-7. PubMed ID: 18488158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of SC-560 in combination with cisplatin or taxol on angiogenesis in human ovarian cancer xenografts.
    Li W; Wan L; Zhai LY; Wang J
    Int J Mol Sci; 2014 Oct; 15(10):19265-80. PubMed ID: 25342321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor properties of taxol in combination with cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian tumor growth in vivo.
    Li W; Zhai L; Tang Y; Cai J; Liu M; Zhang J
    Oncol Res; 2012; 20(2-3):49-59. PubMed ID: 23193911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian carcinoma in vivo.
    Li W; Wang J; Jiang HR; Xu XL; Zhang J; Liu ML; Zhai LY
    Int J Mol Sci; 2011 Jan; 12(1):668-81. PubMed ID: 21340007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cyclooxygenase inhibitors in combination with taxol on expression of cyclin D1 and Ki-67 in a xenograft model of ovarian carcinoma.
    Li W; Cai JH; Zhang J; Tang YX; Wan L
    Int J Mol Sci; 2012; 13(8):9741-9753. PubMed ID: 22949827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers.
    Yokoyama Y; Xin B; Shigeto T; Mizunuma H
    J Cancer Res Clin Oncol; 2011 Aug; 137(8):1219-28. PubMed ID: 21681689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
    Xin B; Yokoyama Y; Shigeto T; Futagami M; Mizunuma H
    Cancer; 2007 Aug; 110(4):791-800. PubMed ID: 17582802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.
    Tortora G; Caputo R; Damiano V; Melisi D; Bianco R; Fontanini G; Veneziani BM; De Placido S; Bianco AR; Ciardiello F
    Clin Cancer Res; 2003 Apr; 9(4):1566-72. PubMed ID: 12684433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts.
    Raut CP; Nawrocki S; Lashinger LM; Davis DW; Khanbolooki S; Xiong H; Ellis LM; McConkey DJ
    Cancer Biol Ther; 2004 Dec; 3(12):1217-24. PubMed ID: 15477758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer.
    Daikoku T; Wang D; Tranguch S; Morrow JD; Orsulic S; DuBois RN; Dey SK
    Cancer Res; 2005 May; 65(9):3735-44. PubMed ID: 15867369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase inhibitors decrease the growth and induce regression of human esophageal adenocarcinoma xenografts in nude mice.
    Santander S; Cebrián C; Esquivias P; Conde B; Esteva F; Jiménez P; Ortego J; Lanas A; Piazuelo E
    Int J Oncol; 2012 Feb; 40(2):527-34. PubMed ID: 21971589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice].
    Zuo CH; Li ZR; Zhou X; Ouyang YZ; Zhou ZY; Zeng L
    Ai Zheng; 2006 Apr; 25(4):414-20. PubMed ID: 16613672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.
    Leahy KM; Ornberg RL; Wang Y; Zweifel BS; Koki AT; Masferrer JL
    Cancer Res; 2002 Feb; 62(3):625-31. PubMed ID: 11830509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study.
    Ferrandina G; Ranelletti FO; Legge F; Lauriola L; Salutari V; Gessi M; Testa AC; Werner U; Navarra P; Tringali G; Battaglia A; Scambia G
    Clin Cancer Res; 2003 Oct; 9(12):4324-31. PubMed ID: 14555502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of celecoxib pharmacodynamics in pancreatic cancer.
    Jimeno A; Amador ML; Kulesza P; Wang X; Rubio-Viqueira B; Zhang X; Chan A; Wheelhouse J; Kuramochi H; Tanaka K; Danenberg K; Messersmith WA; Almuete V; Hruban RH; Maitra A; Yeo CJ; Hidalgo M
    Mol Cancer Ther; 2006 Dec; 5(12):3240-7. PubMed ID: 17172427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer.
    Fu SL; Wu YL; Zhang YP; Qiao MM; Chen Y
    World J Gastroenterol; 2004 Jul; 10(13):1971-4. PubMed ID: 15222049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.